Furthermore, drug selection with sulfasalazine and topotecan induced a complete demethylation of the ABCG2 promoter in the T-ALL and ovarian carcinoma model cell lines CCRF-CEM and IGROV1, respectively.
C1961099
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma